pipette
ENEnglish

Volumetric Analysis of the Deltoid Muscle From Neck-to-Knee Dixon MRI: A pilot population assessment of a posterior intramuscular injection target

M. Niglas, N. Basty, F. Dashti, M. Varadpande, M. Thanaj, A. R. Davies, B. Whitcher, J. Krawczyk, J. D. Bell, E. L. Thomas, D. Amiras

PreprintUso en el mundo real

En palabras de los autores

Abstract Background: Deltoid muscle volume varies across anatomical regions and population groups, with potential implications for intramuscular injection site selection. Evidence comparing middle and posterior deltoid volumes in vaccine-eligible populations is limited. Purpose: To compare middle and posterior deltoid muscle volumes by vaccine eligibility group, sex, and side. Methods: Deltoid muscles were manually segmented into anterior, middle and posterior regions in 43 UK Biobank Dixon MRI scans. A MONAI deep learning model trained on the annotations (Dice score = 0.78) segmented deltoid muscles of 5,239 participants, categorised by UK flu vaccination eligibility: A ([&ge;]65 years without risk conditions, n=1,760), B ([&ge;]65 years with risk conditions, n=1,744), and C (<65 with risk conditions, n=1,735). Bilateral-average posterior and middle volumes were compared using a paired t-test. A linear mixed-effects model assessed posterior-middle differences by group, sex and side. Results: Mean age was 66.7 {+/-} 7.2 years and body mass index was 27.5 {+/-} 5.7 kg/m2 (mean {+/-} SD). Posterior deltoid volume exceeded the middle deltoid volume by 55.36 ml (95% CI, 54.14-56.58, p<0.0001). Posterior-middle differences were largest in Group A, followed by B and then C, greater in men, and greater on the right side (all p<0.0001). Mean segmentation-quality score was 4.27 {+/-} 0.73 on a five-point Likert scale and weighted inter-observer kappa was 0.583 (95% CI, 0.452 - 0.713). Conclusions: Among individuals eligible for the UK flu immunisation, posterior deltoid volume was greater than middle deltoid volume. These findings support further anatomical assessment of the posterior deltoid as a potentially safer injection target.

Resultado principalLimitación que admiten los autores

Apareció: viernes, 13 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.10.26367545